Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-01-19 | 2024-04-05 | 216650 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2025-01-09 | 2025-02-07 | 247379 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-05-24 | 2024-06-14 | 228804 |
| APO-HYDRALAZINE | 10MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18190 |
| APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2019-11-20 | 2019-11-25 | 99299 |
| APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18184 |
| APO-HYDRO | 12.5MG | TABLET | Resolved | 2017-10-11 | 2018-03-06 | 25210 |
| APO-HYDRO | 12.5MG | TABLET | Resolved | 2019-03-05 | 2019-03-29 | 77887 |
| APO-HYDRO | 12.5MG | TABLET | Resolved | 2017-07-25 | 2017-09-15 | 16931 |
| APO-HYDRO | 12.5MG | TABLET | Resolved | 2018-12-12 | 2019-01-17 | 69302 |
| APO-HYDRO | 12.5MG | TABLET | Resolved | 2020-09-02 | 2020-09-09 | 123566 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223083 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2023-11-10 | 2023-11-17 | 209942 |
| APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2023-09-01 | 2023-09-28 | 203548 |
| APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154175 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-11-12 | 2021-12-20 | 149167 |
| APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2023-12-01 | 2024-01-12 | 212383 |
| APO-HYDROMORPHONE | 4MG | TABLET | Resolved | 2023-09-07 | 2023-11-06 | 203852 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-09-21 | 2021-10-25 | 145937 |
| APO-HYDROMORPHONE | 1MG | TABLET | Resolved | 2023-10-27 | 2023-12-15 | 208397 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-LISINOPRIL TABLET 10 MG | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-LISINOPRIL TABLET 20 MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
| APO-LISINOPRIL TABLET 5 MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
| APO-LOPERAMIDE - TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
| APO-LORAZEPAM TAB 0.5MG | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM TAB 1MG | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |